Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa

Abstract Background Genome-wide association studies do not always replicate well across populations, limiting the generalizability of polygenic risk scores (PRS). Despite higher incidence and mortality rates of prostate cancer in men of African descent, much of what is known about cancer genetics co...

Full description

Bibliographic Details
Main Authors: Michelle S. Kim, Daphne Naidoo, Ujani Hazra, Melanie H. Quiver, Wenlong C. Chen, Corinne N. Simonti, Paidamoyo Kachambwa, Maxine Harlemon, Ilir Agalliu, Shakuntala Baichoo, Pedro Fernandez, Ann W. Hsing, Mohamed Jalloh, Serigne M. Gueye, Lamine Niang, Halimatou Diop, Medina Ndoye, Nana Yaa Snyper, Ben Adusei, James E. Mensah, Afua O. D. Abrahams, Richard Biritwum, Andrew A. Adjei, Akindele O. Adebiyi, Olayiwola Shittu, Olufemi Ogunbiyi, Sikiru Adebayo, Oseremen I. Aisuodionoe-Shadrach, Maxwell M. Nwegbu, Hafees O. Ajibola, Olabode P. Oluwole, Mustapha A. Jamda, Elvira Singh, Audrey Pentz, Maureen Joffe, Burcu F. Darst, David V. Conti, Christopher A. Haiman, Petrus V. Spies, André van der Merwe, Thomas E. Rohan, Judith Jacobson, Alfred I. Neugut, Jo McBride, Caroline Andrews, Lindsay N. Petersen, Timothy R. Rebbeck, Joseph Lachance
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Genome Biology
Subjects:
Online Access:https://doi.org/10.1186/s13059-022-02766-z
_version_ 1811267554986950656
author Michelle S. Kim
Daphne Naidoo
Ujani Hazra
Melanie H. Quiver
Wenlong C. Chen
Corinne N. Simonti
Paidamoyo Kachambwa
Maxine Harlemon
Ilir Agalliu
Shakuntala Baichoo
Pedro Fernandez
Ann W. Hsing
Mohamed Jalloh
Serigne M. Gueye
Lamine Niang
Halimatou Diop
Medina Ndoye
Nana Yaa Snyper
Ben Adusei
James E. Mensah
Afua O. D. Abrahams
Richard Biritwum
Andrew A. Adjei
Akindele O. Adebiyi
Olayiwola Shittu
Olufemi Ogunbiyi
Sikiru Adebayo
Oseremen I. Aisuodionoe-Shadrach
Maxwell M. Nwegbu
Hafees O. Ajibola
Olabode P. Oluwole
Mustapha A. Jamda
Elvira Singh
Audrey Pentz
Maureen Joffe
Burcu F. Darst
David V. Conti
Christopher A. Haiman
Petrus V. Spies
André van der Merwe
Thomas E. Rohan
Judith Jacobson
Alfred I. Neugut
Jo McBride
Caroline Andrews
Lindsay N. Petersen
Timothy R. Rebbeck
Joseph Lachance
author_facet Michelle S. Kim
Daphne Naidoo
Ujani Hazra
Melanie H. Quiver
Wenlong C. Chen
Corinne N. Simonti
Paidamoyo Kachambwa
Maxine Harlemon
Ilir Agalliu
Shakuntala Baichoo
Pedro Fernandez
Ann W. Hsing
Mohamed Jalloh
Serigne M. Gueye
Lamine Niang
Halimatou Diop
Medina Ndoye
Nana Yaa Snyper
Ben Adusei
James E. Mensah
Afua O. D. Abrahams
Richard Biritwum
Andrew A. Adjei
Akindele O. Adebiyi
Olayiwola Shittu
Olufemi Ogunbiyi
Sikiru Adebayo
Oseremen I. Aisuodionoe-Shadrach
Maxwell M. Nwegbu
Hafees O. Ajibola
Olabode P. Oluwole
Mustapha A. Jamda
Elvira Singh
Audrey Pentz
Maureen Joffe
Burcu F. Darst
David V. Conti
Christopher A. Haiman
Petrus V. Spies
André van der Merwe
Thomas E. Rohan
Judith Jacobson
Alfred I. Neugut
Jo McBride
Caroline Andrews
Lindsay N. Petersen
Timothy R. Rebbeck
Joseph Lachance
author_sort Michelle S. Kim
collection DOAJ
description Abstract Background Genome-wide association studies do not always replicate well across populations, limiting the generalizability of polygenic risk scores (PRS). Despite higher incidence and mortality rates of prostate cancer in men of African descent, much of what is known about cancer genetics comes from populations of European descent. To understand how well genetic predictions perform in different populations, we evaluated test characteristics of PRS from three previous studies using data from the UK Biobank and a novel dataset of 1298 prostate cancer cases and 1333 controls from Ghana, Nigeria, Senegal, and South Africa. Results Allele frequency differences cause predicted risks of prostate cancer to vary across populations. However, natural selection is not the primary driver of these differences. Comparing continental datasets, we find that polygenic predictions of case vs. control status are more effective for European individuals (AUC 0.608–0.707, OR 2.37–5.71) than for African individuals (AUC 0.502–0.585, OR 0.95–2.01). Furthermore, PRS that leverage information from African Americans yield modest AUC and odds ratio improvements for sub-Saharan African individuals. These improvements were larger for West Africans than for South Africans. Finally, we find that existing PRS are largely unable to predict whether African individuals develop aggressive forms of prostate cancer, as specified by higher tumor stages or Gleason scores. Conclusions Genetic predictions of prostate cancer perform poorly if the study sample does not match the ancestry of the original GWAS. PRS built from European GWAS may be inadequate for application in non-European populations and perpetuate existing health disparities.
first_indexed 2024-04-12T21:04:36Z
format Article
id doaj.art-2fb0ba33d74e488caec70d594a0a5e30
institution Directory Open Access Journal
issn 1474-760X
language English
last_indexed 2024-04-12T21:04:36Z
publishDate 2022-09-01
publisher BMC
record_format Article
series Genome Biology
spelling doaj.art-2fb0ba33d74e488caec70d594a0a5e302022-12-22T03:16:45ZengBMCGenome Biology1474-760X2022-09-0123111610.1186/s13059-022-02766-zTesting the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan AfricaMichelle S. Kim0Daphne Naidoo1Ujani Hazra2Melanie H. Quiver3Wenlong C. Chen4Corinne N. Simonti5Paidamoyo Kachambwa6Maxine Harlemon7Ilir Agalliu8Shakuntala Baichoo9Pedro Fernandez10Ann W. Hsing11Mohamed Jalloh12Serigne M. Gueye13Lamine Niang14Halimatou Diop15Medina Ndoye16Nana Yaa Snyper17Ben Adusei18James E. Mensah19Afua O. D. Abrahams20Richard Biritwum21Andrew A. Adjei22Akindele O. Adebiyi23Olayiwola Shittu24Olufemi Ogunbiyi25Sikiru Adebayo26Oseremen I. Aisuodionoe-Shadrach27Maxwell M. Nwegbu28Hafees O. Ajibola29Olabode P. Oluwole30Mustapha A. Jamda31Elvira Singh32Audrey Pentz33Maureen Joffe34Burcu F. Darst35David V. Conti36Christopher A. Haiman37Petrus V. Spies38André van der Merwe39Thomas E. Rohan40Judith Jacobson41Alfred I. Neugut42Jo McBride43Caroline Andrews44Lindsay N. Petersen45Timothy R. Rebbeck46Joseph Lachance47School of Biological Sciences, Georgia Institute of TechnologyCentre for Proteomic and Genomic ResearchSchool of Biological Sciences, Georgia Institute of TechnologySchool of Biological Sciences, Georgia Institute of TechnologySydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the WitwatersrandSchool of Biological Sciences, Georgia Institute of TechnologyCentre for Proteomic and Genomic ResearchSchool of Biological Sciences, Georgia Institute of TechnologyDepartment of Epidemiology and Population Health, Albert Einstein College of MedicineUniversity of MauritiusFaculty of Medicine and Health Sciences, Stellenbosch UniversityStanford Cancer Institute, Stanford UniversityUniversite Cheikh Anta Diop de DakarUniversite Cheikh Anta Diop de DakarUniversite Cheikh Anta Diop de DakarUniversite Cheikh Anta Diop de DakarUniversite Cheikh Anta Diop de Dakar37 Military Hospital37 Military HospitalKorle-Bu Teaching Hospital and University of Ghana Medical SchoolKorle-Bu Teaching Hospital and University of Ghana Medical SchoolKorle-Bu Teaching Hospital and University of Ghana Medical SchoolDepartment of Pathology, University of Ghana Medical SchoolCollege of Medicine, University of IbadanCollege of Medicine, University of IbadanCollege of Medicine, University of IbadanCollege of Medicine, University of IbadanCollege of Health Sciences, University of Abuja and University of Abuja Teaching HospitalCollege of Health Sciences, University of Abuja and University of Abuja Teaching HospitalCollege of Health Sciences, University of Abuja and University of Abuja Teaching HospitalCollege of Health Sciences, University of Abuja and University of Abuja Teaching HospitalCollege of Health Sciences, University of Abuja and University of Abuja Teaching HospitalNational Cancer Registry, National Health Laboratory ServiceNon-Communicable Diseases Research Division, Wits Health Consortium (PTY) LtdNon-Communicable Diseases Research Division, Wits Health Consortium (PTY) LtdKeck School of Medicine, University of Southern CaliforniaKeck School of Medicine, University of Southern CaliforniaKeck School of Medicine, University of Southern CaliforniaFaculty of Medicine and Health Sciences, Stellenbosch UniversityFaculty of Medicine and Health Sciences, Stellenbosch UniversityDepartment of Epidemiology and Population Health, Albert Einstein College of MedicineHerbert Irving Comprehensive Cancer Center, Columbia UniversityHerbert Irving Comprehensive Cancer Center, Columbia UniversityCentre for Proteomic and Genomic ResearchDana-Farber Cancer InstituteCentre for Proteomic and Genomic ResearchDana-Farber Cancer InstituteSchool of Biological Sciences, Georgia Institute of TechnologyAbstract Background Genome-wide association studies do not always replicate well across populations, limiting the generalizability of polygenic risk scores (PRS). Despite higher incidence and mortality rates of prostate cancer in men of African descent, much of what is known about cancer genetics comes from populations of European descent. To understand how well genetic predictions perform in different populations, we evaluated test characteristics of PRS from three previous studies using data from the UK Biobank and a novel dataset of 1298 prostate cancer cases and 1333 controls from Ghana, Nigeria, Senegal, and South Africa. Results Allele frequency differences cause predicted risks of prostate cancer to vary across populations. However, natural selection is not the primary driver of these differences. Comparing continental datasets, we find that polygenic predictions of case vs. control status are more effective for European individuals (AUC 0.608–0.707, OR 2.37–5.71) than for African individuals (AUC 0.502–0.585, OR 0.95–2.01). Furthermore, PRS that leverage information from African Americans yield modest AUC and odds ratio improvements for sub-Saharan African individuals. These improvements were larger for West Africans than for South Africans. Finally, we find that existing PRS are largely unable to predict whether African individuals develop aggressive forms of prostate cancer, as specified by higher tumor stages or Gleason scores. Conclusions Genetic predictions of prostate cancer perform poorly if the study sample does not match the ancestry of the original GWAS. PRS built from European GWAS may be inadequate for application in non-European populations and perpetuate existing health disparities.https://doi.org/10.1186/s13059-022-02766-zAfricaHealth disparitiesGenomic medicinePolygenic risk scoresPopulation geneticsProstate cancer
spellingShingle Michelle S. Kim
Daphne Naidoo
Ujani Hazra
Melanie H. Quiver
Wenlong C. Chen
Corinne N. Simonti
Paidamoyo Kachambwa
Maxine Harlemon
Ilir Agalliu
Shakuntala Baichoo
Pedro Fernandez
Ann W. Hsing
Mohamed Jalloh
Serigne M. Gueye
Lamine Niang
Halimatou Diop
Medina Ndoye
Nana Yaa Snyper
Ben Adusei
James E. Mensah
Afua O. D. Abrahams
Richard Biritwum
Andrew A. Adjei
Akindele O. Adebiyi
Olayiwola Shittu
Olufemi Ogunbiyi
Sikiru Adebayo
Oseremen I. Aisuodionoe-Shadrach
Maxwell M. Nwegbu
Hafees O. Ajibola
Olabode P. Oluwole
Mustapha A. Jamda
Elvira Singh
Audrey Pentz
Maureen Joffe
Burcu F. Darst
David V. Conti
Christopher A. Haiman
Petrus V. Spies
André van der Merwe
Thomas E. Rohan
Judith Jacobson
Alfred I. Neugut
Jo McBride
Caroline Andrews
Lindsay N. Petersen
Timothy R. Rebbeck
Joseph Lachance
Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa
Genome Biology
Africa
Health disparities
Genomic medicine
Polygenic risk scores
Population genetics
Prostate cancer
title Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa
title_full Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa
title_fullStr Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa
title_full_unstemmed Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa
title_short Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa
title_sort testing the generalizability of ancestry specific polygenic risk scores to predict prostate cancer in sub saharan africa
topic Africa
Health disparities
Genomic medicine
Polygenic risk scores
Population genetics
Prostate cancer
url https://doi.org/10.1186/s13059-022-02766-z
work_keys_str_mv AT michelleskim testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT daphnenaidoo testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT ujanihazra testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT melaniehquiver testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT wenlongcchen testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT corinnensimonti testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT paidamoyokachambwa testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT maxineharlemon testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT iliragalliu testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT shakuntalabaichoo testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT pedrofernandez testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT annwhsing testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT mohamedjalloh testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT serignemgueye testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT lamineniang testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT halimatoudiop testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT medinandoye testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT nanayaasnyper testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT benadusei testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT jamesemensah testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT afuaodabrahams testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT richardbiritwum testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT andrewaadjei testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT akindeleoadebiyi testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT olayiwolashittu testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT olufemiogunbiyi testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT sikiruadebayo testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT oseremeniaisuodionoeshadrach testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT maxwellmnwegbu testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT hafeesoajibola testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT olabodepoluwole testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT mustaphaajamda testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT elvirasingh testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT audreypentz testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT maureenjoffe testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT burcufdarst testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT davidvconti testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT christopherahaiman testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT petrusvspies testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT andrevandermerwe testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT thomaserohan testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT judithjacobson testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT alfredineugut testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT jomcbride testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT carolineandrews testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT lindsaynpetersen testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT timothyrrebbeck testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica
AT josephlachance testingthegeneralizabilityofancestryspecificpolygenicriskscorestopredictprostatecancerinsubsaharanafrica